1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Prostate Cancer Nuclear Medicine Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Prostate Cancer Nuclear Medicine Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Prostate Cancer Nuclear Medicine Market Regional Analysis
6.2 North America Prostate Cancer Nuclear Medicine Market Revenue 2020-2028 (US$ Million)
6.3 North America Prostate Cancer Nuclear Medicine Market Forecast Analysis
7. North America Prostate Cancer Nuclear Medicine Market Analysis – by Type
7.1 PET
- 7.1.1 Overview
- 7.1.2 PET: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 SPECT
- 7.2.1 Overview
- 7.2.2 SPECT: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Prostate Cancer Nuclear Medicine Market Analysis – by PET Product
8.1 F-18
- 8.1.1 Overview
- 8.1.2 F-18: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 C-11
- 8.2.1 Overview
- 8.2.2 C-11: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Ga68-PSMA
- 8.3.1 Overview
- 8.3.2 Ga68-PSMA: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Prostate Cancer Nuclear Medicine Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. North America Prostate Cancer Nuclear Medicine Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Prostate Cancer Nuclear Medicine Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 North America Prostate Cancer Nuclear Medicine Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
- 10.2.1.1.2 US: North America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
- 10.2.1.1.3 US: North America Prostate Cancer Nuclear Medicine Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
- 10.2.1.2.3 Canada: North America Prostate Cancer Nuclear Medicine Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Prostate Cancer Nuclear Medicine Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
- 10.2.1.3.3 Mexico : North America Prostate Cancer Nuclear Medicine Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Blue Earth Diagnostics Limited
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 ImaginAb
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Curium
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Jubilant Radiopharma
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 NCM-USA LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 ABX advanced biochemical compounds GmbH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Telix Pharmaceuticals Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Novartis AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Theragnostics
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Lantheus Medical Imaging, Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Prostate Cancer Nuclear Medicine Market
